Winther Rebecca Rootwelt, Skovlund Eva, Andreassen Joakim Stray, Arvidsson Lisa, Halvardson Jonathan, Solheim Ole, Bartek Jiri, Kaasa Stein, Hjermstad Marianne Jensen, Vik-Mo Einar Osland
European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, Institute of Clinical Medicine, University of Oslo, 4956 Oslo, Norway.
Department of Public Health and Nursing, Norwegian University of Science and Technology, 7034 Trondheim, Norway.
Cancers (Basel). 2023 Jun 13;15(12):3174. doi: 10.3390/cancers15123174.
Brain metastases (BM) are common in cancer patients and are associated with high morbidity and mortality. Surgery is an option, but the optimal selection of patients for surgery is challenging and controversial. Current prognostication tools are not ideal for preoperative prognostication. By using a reference population (derivation data set) and two external populations (validation data set) of patients who underwent surgery for BM, we aimed to create and validate a preoperative prognostic index.
The derivation data set consists of 590 patients who underwent surgery for BM (2011-2018) at Oslo University Hospital. We identified variables associated with survival and created a preoperative prognostic index with four prognostic groups, which was validated on patients who underwent surgery for BM at Karolinska University Hospital and St. Olavs University Hospital during the same time period. To reduce over-fitting, we adjusted the index in accordance with our findings.
438 patients were included in the validation data set. The preoperative prognostic index correctly divided patients into four true prognostic groups. The two prognostic groups with the poorest survival outcomes overlapped, and these were merged to create the adjusted preoperative prognostic index.
We created a prognostic index for patients with BM that predicts overall survival preoperatively. This index might be valuable in supporting informed choice when considering surgery for BM.
脑转移瘤(BM)在癌症患者中很常见,且与高发病率和死亡率相关。手术是一种选择,但对手术患者进行最佳选择具有挑战性且存在争议。目前的预后工具对于术前预后并不理想。通过使用接受BM手术的患者的一个参考人群(推导数据集)和两个外部人群(验证数据集),我们旨在创建并验证一个术前预后指数。
推导数据集由2011年至2018年在奥斯陆大学医院接受BM手术的590例患者组成。我们确定了与生存相关的变量,并创建了一个具有四个预后组的术前预后指数,该指数在同一时期于卡罗林斯卡大学医院和圣奥拉夫斯大学医院接受BM手术的患者中进行了验证。为了减少过度拟合,我们根据研究结果对指数进行了调整。
438例患者被纳入验证数据集。术前预后指数将患者正确地分为四个真正的预后组。生存结果最差的两个预后组重叠,将它们合并以创建调整后的术前预后指数。
我们为BM患者创建了一个术前预测总生存的预后指数。该指数在考虑BM手术时支持明智选择方面可能具有价值。